Navigation Links
MEDEX / Harvard Partnership Now Offers Affordable, New Intelligence to Individual Business & Leisure Travelers
Date:1/29/2008

MEDEX 360m Collaboration with Harvard Medical International Provides

Comprehensive and Vital Global Health Information

BALTIMORE, Jan. 29 /PRNewswire/ -- MEDEX Global Group and Harvard Medical International have extended the reach of their groundbreaking MEDEX 360m partnership with the launch today of a new version created specifically for individual business and leisure travelers.

Like the original MEDEX 360m website recently introduced for corporate, scholastic and government clients, this individual-traveler edition of the MEDEX 360m Global Medical Monitor provides vital and timely health risk and medical care information in an easy-to-read report format.

MEDEX 360m Monitors cover 236 countries and territories with destination- specific information on diseases / health risks; immunization requirements / recommendations; the quality / availability of local care; health alerts / updates; travel health prevention / advice; and health risk ratings. The unique one-to-five rating system allows travelers to quickly see what the primary concerns are for each country -- whether medical infrastructure, remoteness to quality care, or cultural barriers, such as language or local medical practices.

Priced at only $8.95 each, MEDEX 360m Monitors are an easy add-on during the purchase of any individual emergency evacuation or international medical insurance plan; which are priced as low as $2.00 per day or less. The coverage and destination report combination are only available through the MEDEX website: http://www.medex360m.com.

MEDEX 360m Monitors are delivered via a live web link that is active through the last day of their coverage period, so travelers can view their report upon purchase, before and during their trip. Travelers are encouraged revisit their reports to benefit from the up-to-date alerts maintained by MEDEX and Harvard Medical International.

About MEDEX

One of the world's leading emergency medical and security assistance / international medical insurance companies, MEDEX Global Group provides 24/7/365 support for corporations, organizations and individual travelers. Their extensive services include everything from pre-trip intelligence and contingency planning to real-time medical case monitoring, complex emergency evacuations and virtually every contingency in between.

About Harvard Medical International

Harvard Medical International is a self-supporting, not-for-profit subsidiary of Harvard Medical School. HMI's role is to extend internationally, the School's tradition of improving the quality of health care through excellence in clinical medicine, medical education, and biomedical research.

To view a sample MEDEX 360m destination report visit http://www.medex360m.com.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Dr. Walter B. Koppel, MD, MPH, MBA http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=32325


'/>"/>
SOURCE MEDEX Global Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
2. MEDEX 360m Rates the State of Global Medical Care for Travelers
3. How Best to Treat Preschoolers With ADHD? The Harvard Mental Health Letter Discusses the Options
4. Link Uncovered Between Benign Prostatic Hyperplasia and NSAIDs, Says Harvard Mens Health Watch
5. Harvard Researchers Select S.C. BlueCross for National Honor
6. Excessive Multivitamin Use May Raise Risk for Prostate Cancer, from Harvard Mens Health Watch
7. Strawberry Consumption Associated with C-Reactive Protein Among Women: New Harvard Study
8. Fighting the Gassy Effects of Good Eating, From the Harvard Health Letter
9. Cautious Optimism for New Alzheimers Medications, Reports the Harvard Mental Health Letter
10. National healthcare advocate from Harvard Med School to speak at NJIT
11. Antibiotics May Not Help Mens Chronic Pelvic Pain: Harvard Doctors Discuss Alternatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 04, 2016 , ... Safety ... global construction firms representing the Construction Industry Safety Initiative (CISI) and the Incident ... purpose: to inspire everyone in the industry to be leaders in safety. Statistics ...
(Date:5/3/2016)... ... May 04, 2016 , ... The National Association ... into its VIP Woman of the Year Circle. She is recognized with this prestigious ... professional women, boasting more than 850,000 members and over 200 operating Local Chapters. , ...
(Date:5/3/2016)... ... May 03, 2016 , ... According to an article ... issues related to medical care in the hospital setting, which include excessive wait ... hospital staff. Commenting on this article, the founder of House Call Doctor Los ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... 2016 Champion Award to Charles D. Pulido, R.Ph., Co-Founder of NCPDP and member ... Ph.D., Pharmacy Advisor and Health IT Specialist, Office of the National Coordinator for ...
(Date:5/3/2016)... Redondo Beach, CA (PRWEB) , ... May 03, 2016 , ... ... together online to help cancer patients and their families move toward recovery and is ... the focus of today's Dr. Carol Francis Talk Radio show considering medical ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... YORK , May 2, 2016 Kalorama ... EMR (Electronic Medical Records) market in a recent white ... sales, vendor switches, Increased physician usage, a growing market are ... were noted in Kalorama,s report EMR 2016: ... report marks Kalorama,s seventh complete study of the EMR ...
(Date:5/2/2016)... NEW YORK , May 2, 2016 /PRNewswire/ ... Series B financing of Graybug Vision, Inc. Graybug ... to developing therapies that may transform care for ... and glaucoma.  Graybug Vision,s technology was first developed ... out into a startup venture. ...
(Date:5/2/2016)... LAWRENCEVILLE, N.J. , May 2, 2016 /PRNewswire/ ... drug development company, today announced data from the ... dose escalating clinical trial (the OVATION Study) combining ... of care for the treatment of newly-diagnosed patients ... chemotherapy followed by interval debulking surgery.  In the ...
Breaking Medicine Technology: